2025 Europe Biopreservation Market Revenue Opportunities Report
Description
The 2025 Europe Biopreservation Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biopreservation Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European biopreservation market are Thermo Fisher Scientific Inc., Merck KGaA, PHC Holdings Corporation, and BioLife Solutions Inc. Thermo Fisher Scientific leads with a broad portfolio including ultra-low temperature freezers and biopreservation media, extensively supporting research and healthcare sectors across Europe. Merck KGaA, through its Sigma-Aldrich subsidiary, holds a significant market share with diverse bioprocessing tools and cryopreservation solutions tailored for cell therapies and biobanking. PHC Holdings provides advanced laboratory freezers and refrigerators, emphasizing energy-efficient cold storage technologies. BioLife Solutions specializes in biopreservation media for cell therapy and regenerative medicine applications. These companies invest heavily in innovation, product launches, and expansion within Europe to address the growing demand in therapeutic and research applications.
These firms play critical roles in advancing biopreservation technologies in Europe, focusing on improving cell viability and storage stability. Merck KGaA recently unveiled next-generation cryopreservation products targeting biopharma and research sectors, while Thermo Fisher introduced optimized media for cell and gene therapies in 2024. The European market emphasizes sustainability, with companies like BASF (partnered with Acies Bio) exploring eco-friendly preservation methods alongside core leaders. Expanding facilities and R&D centers, continuous product innovation, and strategic collaborations underscore their commitment to maintain and expand their strong presence in the fast-growing European biopreservation sector, projected to exceed USD 3.6 billion by 2033.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biopreservation Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European biopreservation market are Thermo Fisher Scientific Inc., Merck KGaA, PHC Holdings Corporation, and BioLife Solutions Inc. Thermo Fisher Scientific leads with a broad portfolio including ultra-low temperature freezers and biopreservation media, extensively supporting research and healthcare sectors across Europe. Merck KGaA, through its Sigma-Aldrich subsidiary, holds a significant market share with diverse bioprocessing tools and cryopreservation solutions tailored for cell therapies and biobanking. PHC Holdings provides advanced laboratory freezers and refrigerators, emphasizing energy-efficient cold storage technologies. BioLife Solutions specializes in biopreservation media for cell therapy and regenerative medicine applications. These companies invest heavily in innovation, product launches, and expansion within Europe to address the growing demand in therapeutic and research applications.
These firms play critical roles in advancing biopreservation technologies in Europe, focusing on improving cell viability and storage stability. Merck KGaA recently unveiled next-generation cryopreservation products targeting biopharma and research sectors, while Thermo Fisher introduced optimized media for cell and gene therapies in 2024. The European market emphasizes sustainability, with companies like BASF (partnered with Acies Bio) exploring eco-friendly preservation methods alongside core leaders. Expanding facilities and R&D centers, continuous product innovation, and strategic collaborations underscore their commitment to maintain and expand their strong presence in the fast-growing European biopreservation sector, projected to exceed USD 3.6 billion by 2033.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
